Androgen deprivation therapy (castration therapy) and pedophilia: What's new

被引:2
|
作者
Silvani, Mauro [1 ]
Mondaini, Nicola
Zucchi, Alessandro
机构
[1] Infermi Hosp, Urol Dept, Biella, Italy
关键词
Pedophilia; Chemical castration; Andrology;
D O I
10.4081/aiua.2015.3.222
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Andrology is a constantly evolving discipline, embracing social problems like pedophilia and its pharmacological treatment. With regard to chemical castration, the andrologist may perform an important role as part of a team of specialists. At present, no knowledge is available regarding hormonal, chromosomal or genetic alterations involved in pedophilia. International legislation primarily aims to defend childhood, but does not provide for compulsory treatment. We reviewed international literature that, at present, only comprises a few reports on research concerning androgen deprivation. Most of these refer to the use of leuprolide acetate, rather than medroxyprogesterone and cyproterone acetate, which present a larger number of side effects. Current opinions on chemical castration for pedophilia are discordant. Some surveys confirm that therapy reduces sexual thoughts and fantasies, especially in recidivism. On the other hand, some authors report that chemical castration does not modify the pedophile's personality. In our opinion, once existing legislation has changed, andrologists could play a significant role in the selection of patients to receive androgen deprivation therapy, due in part to their knowledge about its action and side effects.
引用
收藏
页码:222 / 226
页数:5
相关论文
共 50 条
  • [1] How do we define "castration" in men on androgen deprivation therapy?
    Itty, Sarin
    Getzenberg, Robert H.
    [J]. ASIAN JOURNAL OF ANDROLOGY, 2020, 22 (05) : 441 - 446
  • [2] Androgen Deprivation Therapy and Alzheimer's Disease
    Froehner, Michael
    Wirth, Manfred P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (23) : 2801 - +
  • [3] Androgen deprivation therapy and cardiovascular disease: what is the linking mechanism?
    Zareba, Piotr
    Duivenvoorden, Wilhelmina
    Leong, Darryl P.
    Pinthus, Jehonathan H.
    [J]. THERAPEUTIC ADVANCES IN UROLOGY, 2016, 8 (02) : 118 - 129
  • [4] Androgen deprivation therapy and postprostatectomy radiation: What is the optimal duration?
    Yang, David D.
    Wu, Jing
    D'Amico, Anthony V.
    [J]. CANCER, 2024,
  • [5] Evaluation of maintenance of the common androgen deprivation therapy with the new antiandrogen therapy in patients with castration-resistant prostate cancer: a systematic review
    Carla Manzoni Salgado
    Herney Andrés Garcia-Perdomo
    Leonardo O. Reis
    [J]. International Urology and Nephrology, 2022, 54 : 1187 - 1192
  • [6] Evaluation of maintenance of the common androgen deprivation therapy with the new antiandrogen therapy in patients with castration-resistant prostate cancer: a systematic review
    Salgado, Carla Manzoni
    Garcia-Perdomo, Herney Andres
    Reis, Leonardo O.
    [J]. INTERNATIONAL UROLOGY AND NEPHROLOGY, 2022, 54 (06) : 1187 - 1192
  • [7] Androgen deprivation therapy for prostate cancer: New developments
    Rabbani, F
    Fair, WR
    [J]. INFECTIONS IN UROLOGY, 1999, 12 (04): : 104 - +
  • [8] Androgen deprivation therapy complications
    Allan, Carolyn A.
    Collins, Veronica R.
    Frydenberg, Mark
    McLachlan, Robert I.
    Matthiesson, Kati L.
    [J]. ENDOCRINE-RELATED CANCER, 2014, 21 (04) : T119 - T129
  • [9] Osteoporosis and androgen deprivation therapy
    Adami, S
    [J]. OSTEOPOROSIS INTERNATIONAL, 2003, 14 : S21 - S21
  • [10] Metformin and Androgen Deprivation Therapy
    Hsu, Chen-Xiong
    Shueng, Pei-Wei
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 116 (03): : 694 - 694